Cosmetic Compliance
Intelligence & Solutions
Home / News / Details

Korea Revises Quasi Drug Evaluation Requirements

Korea adjusted the existing evaluation requirements for quasi drugs to align with the new quasi drug reevaluation scheme implemented on December 4th 2015. Enlarge the scope of high risk ingredients MFDS newly adds polyhexamethylene guanidine hydrochloride (PHMG), oligo (2-2-ethyoxy) ethoxyethylguanidim chloride (PGH), cetylpyridinum chloride (CPC) -- when concentration above 0.05%, and dipropylisocinchomeronate into the scope of high risk ingredients which can potentially cause cellular damage. Both PHMG and PGH have been discovered as risk factors in the development of lung disease if inhaled. The preparations of inhalation, spray,

Korea adjusted the existing evaluation requirements for quasi drugs to align with the new quasi drug reevaluation scheme implemented on December 4th 2015.

Please Log in or Sign up (FREE) to read the full content.
We provide full-scale global cosmetic market entry services (including cosmetic registering & filing, regulatory consultation, customized training, market research, branding strategy). Please contact us to discuss how we can help you by cosmetic@chemlinked.com
Copyright: unless otherwise stated all contents of this website are ©2024 - REACH24H Consulting Group - All Rights Reserved - For permission to use any content on this site, please contact cleditor@chemlinked.com